PharmaCyte Biotech's total assets for Q were $55.10M, a decrease of -21.51% from the previous quarter. PMCB total liabilities were $11.65M for the fiscal quarter, a -32.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.